Active VGF Nerve Growth Factor Inducible (VGF) Homo sapiens (Human) Active protein

NERP1; NERP2; Neuro-Endocrine Specific Protein VGF; Neuroendocrine Regulatory Peptide

No quotes Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point4.4
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active VGF Nerve Growth Factor Inducible (VGF) Packages (Simulation)
  • Active VGF Nerve Growth Factor Inducible (VGF) Packages (Simulation)
  • APB166Hu63.jpg Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

VGF (nerve growth factor inducible) is a secretory polypeptide precursor belonging to the granin/secretogranin family, selectively expressed in neuronal and neuroendocrine cells. It promotes cell proliferation, survival, and migration, while inhibiting apoptosis in neurons and multiple cancer cell types. VGF drives oncogenic signaling, enhances therapy resistance, and facilitates epithelial–mesenchymal transition. Its proteolytic products mediate neurogenesis, energy homeostasis, and tumor progression, positioning VGF as a key regulator in neural function and cancer pathogenesis.To test the effect of VGF on cell apoptosis, A549 cells were seeded into triplicate wells of 96-well plates and allowed to attach, replaced with various concentrations of recombinant human VGF. After incubated for 48 hours, cells were observed by inverted microscope and cell proliferation was measured by Cell Counting Kit-8 (CCK-8). Briefly, 10 µl of CCK-8 solution was added to each well of the plate, then the absorbance at 450 nm was measured using a microplate reader after incubating the plate for 1-4 hours at 37 ℃. Cell viability was assessed by CCK-8 (Cell Counting Kit-8 ) assay after incubation with recombinant human VGF for 48 hours. The result was shown in Figure 1. It was obvious that VGF significantly decreased cell viability of A549 cells.The ED50 of recombinant human VGF is 230 ng/mL.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesityPubMed: 22296024
  • Low VGF is associated with executive dysfunction in patients with major depressive disorderPubmed:35738161

Recommend products